GMP Cas9 nuclease is an RNA-guided DNA endonuclease produced under stringent manufacturing protocols for high-fidelity in vitro genomic cleavage and target-specific sequence editing. Designed strictly for laboratory research and preclinical evaluation, this enzyme facilitates targeted double-stranded breaks when complexed with single-guide RNA. PX1 Research supplies high-purity recombinant reagents backed by lot-specific analytical characterization.
GMP Cas9 nuclease is an RNA-guided DNA endonuclease produced under stringent manufacturing protocols for high-fidelity in vitro genomic cleavage and target-specific sequence editing. Designed strictly for laboratory research and preclinical evaluation, this enzyme facilitates targeted double-stranded breaks when complexed with single-guide RNA. PX1 Research supplies high-purity recombinant reagents backed by lot-specific analytical characterization.
GMP Cas9 nuclease is a recombinant RNA-guided endonuclease derived from Streptococcus pyogenes and produced under Good Manufacturing Practice (GMP) quality standards to ensure high batch-to-batch consistency, low endotoxin levels, and structural integrity. In laboratory research, it functions by forming a ribonucleoprotein (RNP) complex with a single-guide RNA (sgRNA), directing sequence-specific double-stranded DNA cleavage at target loci containing a canonical protospacer adjacent motif (PAM).
Unlike crude or basic research-grade enzyme preparations, enzyme reagents produced under GMP-compliant environments undergo rigorous quality assurance to eliminate host cell protein contaminants, non-specific nucleases, and microbial endotoxins. This level of control is essential for sensitive molecular assays, high-throughput targeted sequencing preparation, cell-free enzyme kinetics assays, and preclinical gene disruption models where experimental noise from impurity-induced cytotoxicity or off-target cleavage must be minimized.
Supplied exclusively as a research compound for in vitro and laboratory experimentation, gmp cas9 nuclease provides researchers with a reproducible tool for dissecting genomic architecture, evaluating target site accessibility, and investigating double-strand break repair mechanisms across diverse cell-free and cultured cell assays.
The Cas9 endonuclease is a multidomain protein consisting of two primary structural lobes: the recognition (REC) lobe and the nuclease (NUC) lobe. The REC lobe mediates binding to the sgRNA guide scaffold and target DNA heteroduplex, while the NUC lobe contains two distinct catalytic domains: the HNH domain and the RuvC domain. Each domain is responsible for cleaving one strand of the target double-stranded DNA substrate.
Upon hybridization between the 20-nucleotide spacer region of the guide RNA and the complementary target DNA strand, the HNH domain cleaves the target strand (complementary to the gRNA) three base pairs upstream of the 5'-NGG-3' PAM sequence. Simultaneously, the RuvC domain cleaves the non-target strand, generating a blunt-ended double-strand break (DSB). In vitro enzymatic assays demonstrate that the catalytic rate of Cas9 cleavage is highly dependent on target sequence matching, local chromatin accessibility, and magnesium ion concentration within the reaction buffer.
Biochemical evaluations published in the research library highlight that RNP-mediated delivery of Cas9—combining recombinant Cas9 protein with synthetic sgRNA prior to introduction into target systems—yields immediate catalytic activity followed by rapid enzymatic turnover. This transient presence reduces long-term endonuclease persistence within experimental models, which preclinical studies suggest substantially decreases off-target cleavage compared to vector-based continuous expression systems.
The classification of a reagent under GMP standards reflects strict adherence to standardized manufacturing procedures, environmental monitoring, facility compliance, and quality control verification. For molecular biologists conducting foundational research or developing scalable cellular assays, utilizing reagents manufactured under these conditions ensures high fidelity and reproducible outcomes.
In cell culture models and primary cell research, trace impurities such as residual bacterial endotoxins (lipopolysaccharides), host cell DNA, or foreign proteases can trigger unspecific inflammatory pathways or degrade delicate synthetic RNA guides. GMP-compliant manufacturing eliminates these confounding variables by utilizing cleanroom environments, validated purification processes, and stringent bioburden testing.
Furthermore, lot-to-lot consistency is vital when quantifying target cleavage efficiency or screening sgRNA libraries. Variations in enzyme concentration, specific activity, or structural degradation can skew experimental metrics. Reagents sourced through verified suppliers with dedicated US manufacturing capabilities provide documented assurance that enzymatic performance remains consistent across extended experimental timelines.
In vitro data indicate that recombinant Cas9 nuclease serves as a versatile tool across multiple laboratory disciplines. One prominent application involves cell-free digestion assays, where researchers assess sgRNA cleavage efficiency prior to downstream transfection studies. By incubating target plasmid or PCR amplicon DNA with the assembled RNP complex, researchers can measure cleavage kinetics and target site selectivity via agarose gel electrophoresis or capillary fragment analysis.
In preclinical cellular assays, Cas9 RNPs are routinely electroporated into cultured cell lines or primary stem cell populations to analyze DNA repair pathways, including Non-Homologous End Joining (NHEJ) and Homology-Directed Repair (HDR). When co-delivered with donor DNA templates, Cas9 facilitates precise sequence insertion studies, enabling the functional annotation of genomic variants.
Preclinical studies suggest that high-purity Cas9 preparations are also instrumental in developing high-throughput target-enrichment protocols for next-generation sequencing (NGS). By selectively cleaving unwanted genomic regions or isolated target loci, researchers utilize Cas9 to enrich specific target fragments without requiring PCR amplification, preserving native DNA methylation patterns for epigenetic research.
To verify that recombinant protein reagents meet stringent research requirements, rigorous analytical testing must be performed on every production lot. Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) is utilized to determine overall protein purity, resolving monomeric full-length Cas9 from truncated fragments or aggregated species. High-grade research reagents routinely exhibit purities exceeding 95% by HPLC area integration.
Mass Spectrometry (MS) provides exact molecular mass verification and sequence identification, confirming the complete amino acid sequence and identifying potential post-translational modifications or chemical degradation products. This mass confirmation ensures that the catalytic HNH and RuvC domain residues remain intact and fully functional.
Endotoxin contamination represents a major source of experimental artifact in primary cell culture and ex vivo research assays. Bacterial endotoxins are quantified using standardized Limulus Amebocyte Lysate (LAL) or recombinant Factor C assays. High-purity research compounds are certified to contain minimal endotoxin levels—typically below 0.1 EU/µg of protein—ensuring that cellular responses observed during experiments reflect the intended genetic manipulation rather than immune activation caused by impurity.
When designing genome modification experiments, researchers must select the appropriate endonuclease based on target PAM availability, cleavage geometry, and desired specificity. Cas9 remains the benchmark enzyme for blunt-ended target cleavage requiring a short 5'-NGG-3' PAM motif. However, alternative endonucleases offer distinct advantages under specific biochemical conditions.
For example, Cas12a nuclease research focuses on an enzyme that recognizes a T-rich PAM sequence (5'-TTTV-3') and generates staggered 5' overhang cleavage products. This staggered cleavage can favor specific repair pathways in certain cellular models. Similarly, modified gene-editing enzymes such as Cas9 nickases (which deactivate one catalytic domain to yield single-stranded nicks) and dCas9 (catalytically inactive Cas9 fused to transcriptional regulators) extend the utility of the system beyond double-stranded breaks.
Choosing between classic SpCas9, modified nickases, or alternative systems like Cas12a depends on target sequence architecture and experimental design. Sourcing these compounds through specialized providers of research peptides ensures that all comparative assays utilize reagents characterized under identical purity and endotoxin standards.
Maintaining the enzymatic activity of recombinant Cas9 nuclease requires strict adherence to recommended laboratory handling guidelines. Cas9 is typically supplied as a frozen liquid in a storage buffer containing glycerol, sodium chloride, tris-HCl, and reducing agents like DTT or TCEP to stabilize the tertiary protein structure and prevent oxidation of cysteine residues.
Upon receipt, reagents should be stored at -80°C for long-term preservation, or at -20°C in a manual defrost freezer for short-term use. Repeated freeze-thaw cycles must be avoided, as ice crystal formation can denature the protein and induce aggregation, leading to a loss of cleavage activity. Researchers are advised to prepare single-use aliquots using sterile, nuclease-free microcentrifuge tubes immediately following initial thawing.
For in vitro cleavage assays, Cas9 should be diluted in dedicated reaction buffers containing 20 mM HEPES (pH 7.5), 150 mM KCl, 10 mM MgCl2, and 0.5 mM DTT. Assembly of the RNP complex is achieved by incubating Cas9 protein with sgRNA at a recommended molar ratio (typically 1:1 to 1:3) at room temperature for 10 to 15 minutes prior to adding the target DNA substrate.
Sourcing high-quality research tools requires evaluating supplier transparency and manufacturing infrastructure. Laboratory researchers should demand a lot-specific Certificate of Analysis (COA) for every batch of endonuclease purchased. A comprehensive COA documents mass spectrometry verification, RP-HPLC purity profiles, SDS-PAGE purity analysis, endotoxin quantification, and specific cleavage activity assays.
PX1 Research emphasizes domestic manufacturing within ISO 17025 accredited and GMP-compliant facilities. Domestic US synthesis and packaging eliminate transit delays and freeze-thaw risks associated with international shipping, ensuring reagent stability upon arrival. Orders are fulfilled with same-day shipping from facilities in California and Arizona.
For research institutions, academic laboratories, and biotechnology firms requiring scaled supply for screening platforms, establishing direct access via wholesale lab accounts ensures reliable lot availability, consistent batch characterization, and direct technical support for analytical inquiries.
What is GMP Cas9 nuclease used for in research?
GMP Cas9 nuclease is used in laboratory research for site-specific DNA cleavage, targeted gene disruption assays, single-guide RNA screening, and developing in vitro genomic enrichment protocols. It is intended strictly for in vitro and preclinical research applications.
How does GMP Cas9 differ from standard research-grade Cas9?
GMP Cas9 is manufactured under Good Manufacturing Practice protocols, ensuring strict environmental controls, higher lot-to-lot consistency, minimal endotoxin levels, and comprehensive analytical documentation including HPLC, mass spec, and bioburden validation.
What PAM sequence is recognized by Streptococcus pyogenes Cas9?
SpCas9 recognizes a 5'-NGG-3' protospacer adjacent motif (PAM) located immediately downstream on the 3' side of the target DNA strand.
What is the recommended storage temperature for recombinant Cas9 nuclease?
Recombinant Cas9 nuclease should be stored at -80°C for long-term stability. Aliquots may be kept at -20°C in non-frost-free freezers to avoid repeated freeze-thaw cycles.
What analytical tests verify the purity of Cas9 nuclease at PX1 Research?
PX1 Research verifies Cas9 reagents using Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) for protein purity, Mass Spectrometry (MS) for structural identity, SDS-PAGE analysis, and LAL assays for endotoxin quantification.
How is the Cas9 ribonucleoprotein (RNP) complex assembled in the lab?
Cas9 RNP complexes are assembled by combining recombinant Cas9 protein with synthetic single-guide RNA (sgRNA) in a reaction buffer containing magnesium ions and incubating at room temperature (20–25°C) for 10–15 minutes.
What endotoxin levels are acceptable for in vitro cell culture assays?
For sensitive cell culture and primary cell research, endotoxin levels should ideally be below 0.1 EU/µg of protein to prevent non-specific cellular activation or cytotoxicity.
Can PX1 Research provide bulk quantities of Cas9 nuclease for enterprise labs?
Yes, PX1 Research provides batch-consistent research reagents at scale through wholesale lab accounts, complete with lot-specific COAs and full analytical documentation.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.